脊椎ポンプ市場- 世界の産業規模、シェア、動向、機会、予測、2018年～2028年用途別、エンドユーザー別、地域別、競合別分析

脊椎ポンプの世界市場は、2022年に3億5,230万米ドルと評価され、予測期間にはCAGR 8.75%の目覚ましい成長が見込まれています。

脊椎ポンプは、髄腔内ドラッグデリバリーシステムまたは単にポンプとしても知られ、脊髄内の脳脊髄液（CSF）に直接薬剤を標的送達するために使用される医療機器です。このドラッグデリバリーの方法は、中枢神経系への薬剤の正確かつ制御された投与を可能にし、特に疼痛管理や特定の病状の治療においていくつかの利点をもたらします。脊椎ポンプは、腰痛手術失敗症候群、複合性局所疼痛症候群（CRPS）、神経障害性疼痛、がん性疼痛など、他の治療法に反応しない慢性疼痛や重症疼痛の管理によく使用されます。脊椎ポンプは、バクロフェンなどの筋弛緩剤を脊髄に直接投与することで、多発性硬化症（MS）、脳性麻痺、脊髄損傷などの症状における重度の痙縮を管理するのに役立ちます。脊椎ポンプは、ジストニア、特定の運動障害、膀胱、腸の機能障害、場合によっては精神疾患や難治性てんかんなどの疾患の治療にも使用されます。

背部手術失敗症候群、複合性局所疼痛症候群、がん関連疼痛などの慢性疼痛症状の有病率の増加は、脊椎ポンプ市場の重要な促進要因です。これらの疾患では、脊椎ポンプを含む高度な疼痛管理ソリューションが必要とされることが多いです。脊椎ポンプの設計と機能性における継続的な技術進歩により、その精度、安全性、使いやすさが向上しています。これらの技術革新により、脊椎ポンプ療法はより効果的になり、ヘルスケアプロバイダーや患者にとって魅力的なものとなっています。脊椎ポンプは、疼痛管理計画のカスタマイズを可能にします。ヘルスケアプロバイダーは、患者固有の痛みのニーズに合わせて投薬量や投与速度を調整することができ、その結果、痛みのコントロールと患者の転帰が改善されます。

主な市場促進要因

技術の進歩

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 脊椎用ポンプの世界市場展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • 用途別（悪性疼痛、非悪性疼痛、疼痛管理、痙縮管理）
  • エンドユーザー別（代替ケアセンター、ASC、クリニック、病院、長期ケアセンター）
  • 企業別（2022年）
• 市場マップ

第6章 アジア太平洋地域の脊椎ポンプ市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 用途別
  • エンドユーザー別
  • 国別
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • オーストラリア
  • 日本
  • 韓国

第7章 欧州脊椎ポンプ市場展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • 用途別
  • エンドユーザー別
  • 国別
• 欧州：国別分析
  • フランス
  • ドイツ
  • スペイン
  • イタリア
  • 英国

第8章 北米脊椎ポンプ市場展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • 用途別
  • エンドユーザー別
  • 国別
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第9章 南米の脊椎ポンプ市場展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • 用途別
  • エンドユーザー別
  • 国別
• 南米：：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの脊椎ポンプ市場展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • 用途別
  • エンドユーザー別
  • 国別
• MEA：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 製品上市
• 合併と買収

第13章 脊椎ポンプの世界市場SWOT分析

第14章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第15章 PESTLE分析

第16章 競合情勢

• Medtronic Plc.
• FlowonixMedical, Inc.
• Tricumed Medizintechnik GmbH
• Smith Group Plc
• Johnson & Johnson Private Limited
• Teleflex, Inc.
• Becton Dickinson & Co.
• DePuy Synthes Inc.

第17章 戦略的提言

Global Spinal Pumps Market has valued at USD 352.30 million in 2022 and is anticipated to witness an impressive growth in the forecast period with a CAGR of 8.75%. A spinal pump, also known as an intrathecal drug delivery system or simply a pump, is a medical device used for the targeted delivery of medications directly into the cerebrospinal fluid (CSF) within the spinal cord. This method of drug delivery allows for precise and controlled administration of medications to the central nervous system, offering several advantages, particularly in pain management and the treatment of specific medical conditions. Spinal pumps are commonly used to manage chronic and severe pain conditions that are unresponsive to other treatments, such as failed back surgery syndrome, complex regional pain syndrome (CRPS), neuropathic pain, and cancer-related pain. Spinal pumps can help manage severe spasticity in conditions like multiple sclerosis (MS), cerebral palsy, and spinal cord injury by delivering muscle relaxants like baclofen directly to the spinal cord. Spinal pumps are also used to treat conditions such as dystonia, certain movement disorders, bladder, and bowel dysfunction, and, in some cases, psychiatric disorders and refractory epilepsy.

The increasing prevalence of chronic pain conditions, such as failed back surgery syndrome, complex regional pain syndrome, and cancer-related pain, is a significant driver of the Spinal Pumps Market. These conditions often require advanced pain management solutions, including spinal pumps. Ongoing technological advancements in the design and functionality of spinal pumps have improved their precision, safety, and ease of use. These innovations make spinal pump therapy more effective and attractive to healthcare providers and patients. Spinal pumps allow for the customization of pain management plans. Healthcare providers can tailor medication dosages and delivery rates to meet each patient's unique pain needs, resulting in better pain control and patient outcomes.

Key Market Drivers

Advancements in Technology

Modern spinal pumps are often programmable, allowing healthcare providers to adjust medication dosages and delivery rates remotely. This flexibility enables personalized pain management plans tailored to each patient's needs. Some spinal pumps offer microdosing capabilities, allowing for extremely precise drug delivery. This is particularly beneficial when patients require very low doses of medication or need highly controlled pain management. Advanced spinal pumps are equipped with continuous monitoring and data logging features. These capabilities enable healthcare providers to track the performance of the pump, medication usage, and patient responses over time. Spinal pumps can now be remotely monitored and adjusted using wireless or remote-control devices. Healthcare providers can make real-time adjustments to medication delivery without the need for in-person visits, improving patient convenience. Modern spinal pumps include integrated alarm systems that alert both healthcare providers and patients to any issues or anomalies, such as low medication levels or technical malfunctions. Battery technology has improved, leading to longer-lasting power sources for spinal pumps. This enhances the reliability of these devices and reduces the need for frequent battery replacements. Noise reduction technologies have been integrated into spinal pump designs, making them quieter and less noticeable to patients.

Surgical techniques for implanting spinal pumps have become less invasive, resulting in shorter recovery times and reduced patient discomfort. Spinal pump manufacturers have worked to improve medication compatibility and reduce the risk of medication precipitation or clogging within the pump system. Spinal pumps can be integrated with other medical technologies, such as patient-controlled analgesia (PCA) systems or electronic health records (EHRs), to streamline patient care and data management. Some spinal pump systems offer smartphone apps that allow patients to monitor and track their medication delivery, receive reminders for refills, and communicate with their healthcare providers. Safety features, such as tamper-evident designs and mechanisms to prevent medication overdose, have been integrated into spinal pump systems to enhance patient safety. Advanced spinal pumps may offer dose titration capabilities, allowing healthcare providers to gradually adjust medication dosages to achieve optimal pain control while minimizing side effects. Technological improvements have extended the lifespan of spinal pumps, reducing the frequency of device replacements. Ongoing research and development efforts continue to explore new technologies, materials, and delivery mechanisms for spinal pumps, with the aim of further improving patient outcomes and device safety. This factor will help in the development of the Global Spinal Pumps Market.

Increasing Prevalence of Chronic Pain

As the global population continues to age, the incidence of chronic pain increases. Older adults are more likely to experience chronic pain due to age-related conditions such as osteoarthritis, degenerative spine disorders, and neuropathic pain. Advances in healthcare have led to longer life expectancies, but this has also resulted in a higher likelihood of experiencing age-related health issues, including chronic pain conditions. Obesity is a risk factor for chronic pain conditions, including musculoskeletal pain, osteoarthritis, and neuropathic pain. The global rise in obesity rates has contributed to the prevalence of chronic pain. Modern lifestyles often involve extended periods of sitting, which can lead to musculoskeletal pain and discomfort, especially in the back and neck. Sedentary behavior is associated with an increased risk of developing chronic pain.

Chronic pain is often comorbid with other chronic health conditions such as diabetes, cardiovascular disease, and autoimmune disorders. As the prevalence of these conditions increases, so does the likelihood of chronic pain. Stress, anxiety, depression, and other psychological factors can exacerbate and contribute to the development of chronic pain. The global mental health crisis has added to the burden of pain-related conditions. Some professions and occupations involve physical demands or repetitive motions that increase the risk of chronic pain and musculoskeletal disorders. Previous injuries, accidents, or trauma can lead to chronic pain, even long after the initial injury has healed. Paradoxically, the opioid epidemic, driven by the overuse and misuse of prescription opioids, has contributed to the prevalence of chronic pain. Prolonged opioid use can lead to a phenomenon known as opioid-induced hyperalgesia, where patients experience increased sensitivity to pain. Advances in medical diagnostics have improved the identification and diagnosis of chronic pain conditions, leading to more accurate prevalence estimates. Increased awareness of chronic pain and its impact on quality of life has led more individuals to seek medical attention and report their symptoms to healthcare providers. This factor will pace up the demand of the Global Spinal Pumps Market.

Expansion of Indications in Spinal Pumps

Pain management remains the primary and most well-established indication for spinal pumps. They are commonly used to treat chronic pain conditions such as failed back surgery syndrome, complex regional pain syndrome (CRPS), neuropathic pain, and cancer-related pain. Spinal pumps are utilized to manage severe spasticity in conditions such as multiple sclerosis (MS), cerebral palsy, and spinal cord injury. Intrathecal baclofen, a muscle relaxant, is often delivered via spinal pumps to reduce muscle spasticity and improve mobility. In addition to opioid medications, intrathecal pumps can deliver other analgesic agents, such as local anesthetics, to provide effective pain relief for specific medical procedures or post-operative pain management. Spinal pumps are used to manage pain and spasticity in individuals with spinal cord injuries, helping improve their quality of life and functional independence.

Patients with neuropathic pain, which is often challenging to manage with oral medications, can benefit from intrathecal drug delivery. Medications like ziconotide may be delivered directly to the cerebrospinal fluid to target neuropathic pain receptors. Spinal pumps are increasingly used to manage cancer-related pain, especially in patients with advanced-stage cancer. They offer an effective means of pain control when oral or systemic opioids are insufficient or cause intolerable side effects. Spinal pumps are used in the treatment of severe dystonia, a neurological movement disorder characterized by muscle contractions and abnormal postures. Intrathecal delivery of antispasmodic medications may be considered as an adjunctive therapy for the management of refractory epilepsy in some cases. Children with cerebral palsy who experience severe spasticity and pain may benefit from intrathecal baclofen delivered through spinal pumps. Some research is exploring the use of intrathecal drug delivery for psychiatric disorders like obsessive-compulsive disorder (OCD) and major depressive disorder. These studies are in the early stages and are considered experimental. Spinal pumps are being investigated for their potential role in managing movement disorders such as Parkinson's disease and dystonia. Intrathecal delivery of medications can also be used to manage bladder and bowel dysfunction in certain neurological conditions. This factor will accelerate the demand of the Global Spinal Pumps Market.

Key Market Challenges

Cost Containment

The upfront cost of acquiring and implanting a spinal pump system can be substantial. This includes the cost of the pump device itself, surgical implantation, hospitalization, and other associated expenses. High initial costs can be a barrier for healthcare facilities and patients. Many spinal pump systems deliver specialized medications that are often more expensive than oral equivalents. The ongoing cost of medications used in spinal pumps can be a financial burden, particularly for long-term therapy. Spinal pump systems require periodic refilling of medication reservoirs, typically every few weeks or months. These refilling procedures come with associated costs for healthcare facilities and patients. Surgical implantation of the spinal pump, as well as follow-up visits for adjustments and monitoring, can add to the overall cost of treatment. The utilization of healthcare resources, including surgical teams, anesthesiologists, pain management specialists, and nurses, contributes to the overall cost of spinal pump therapy. Healthcare facilities must allocate these resources effectively. Ensuring adequate reimbursement for spinal pump therapy is a complex process. It can involve negotiations with insurance providers and adherence to specific criteria for coverage, making it challenging for healthcare facilities and patients to secure financial support. Access to healthcare facilities and providers with expertise in spinal pump therapy may be limited in certain regions, leading to higher costs associated with travel and specialized care.

Safety and Infection Control

The surgical implantation of spinal pumps carries inherent risks, including bleeding, infection, damage to surrounding tissues, and cerebrospinal fluid leaks. Minimizing surgical complications is crucial for patient safety. Infections are a significant concern in spinal pump therapy. The presence of a foreign body (the implanted pump) increases the risk of bacterial colonization and infection. Infections can lead to serious complications, including meningitis or device removal. Surgical procedures for implanting and maintaining spinal pumps require strict adherence to sterile techniques to minimize infection risk. Any breach in sterile procedure can increase the likelihood of infection. The accurate placement of the catheter within the intrathecal space is crucial. Improper placement can lead to inadequate drug delivery or complications such as spinal cord injury. Ensuring the sterility of medications used in spinal pumps is essential to prevent contamination. Contaminated medications can introduce bacteria or other pathogens into the central nervous system. Regular monitoring and surveillance of patients with spinal pumps are necessary to detect early signs of complications, including infections or catheter-related issues. Prompt intervention can prevent serious problems. Educating patients about proper care and hygiene related to their spinal pump system is essential. Patients should be aware of signs of infection, such as redness, swelling, fever, or increased pain, and should report these symptoms promptly.

Key Market Trends

Rising Adoption of Implantable Pumps

Implantable pumps allow for highly precise and controlled drug delivery directly to the cerebrospinal fluid within the spinal cord. This targeted approach minimizes systemic side effects and maximizes the therapeutic effect of medications, making it particularly valuable in pain management and spasticity control. Implantable pumps are highly effective in managing chronic and severe pain conditions that are often refractory to other treatment methods. Patients with conditions like failed back surgery syndrome, complex regional pain syndrome (CRPS), and cancer-related pain benefit from better pain control and improved quality of life. The use of implantable pumps can reduce a patient's reliance on oral or systemic medications, particularly opioids. This is significant in the context of the opioid epidemic and concerns about opioid-related side effects and dependence. Implantable pumps allow for individualized treatment plans. Healthcare providers can adjust medication dosages, delivery rates, and schedules to meet each patient's specific needs, improving the overall quality of care. With implantable pumps, medication waste is minimized because drugs are delivered directly to the target site. This is an important consideration for healthcare cost containment and sustainability. Implantable pumps can provide long-term therapy for chronic conditions, reducing the need for frequent medication adjustments and improving patient adherence. Once implanted, these devices require less day-to-day attention from patients compared to external devices, such as transdermal patches or oral medications. This can lead to improved patient compliance and quality of life.

Segmental Insights

Application Insights

In 2022, the Global Spinal Pumps Market largest share was held by Pain Management segment and is predicted to continue expanding over the coming years. Chronic pain is a significant healthcare issue worldwide, and it affects millions of individuals. Conditions such as failed back surgery syndrome, complex regional pain syndrome, and cancer-related pain can be extremely debilitating. Spinal pumps are a valuable tool in managing chronic pain that is often refractory to other treatment modalities. Spinal pumps offer a highly effective method for delivering pain medications, such as opioids or other analgesics, directly to the spinal cord. This targeted drug delivery allows for precise pain control, often with lower doses of medications compared to oral or systemic administration. As a result, patients can experience better pain relief and improved quality of life. Intrathecal drug delivery through spinal pumps minimizes the systemic side effects often associated with high-dose oral or intravenous pain medications. This is particularly beneficial for patients who may have difficulty tolerating systemic opioids or who require high doses for adequate pain relief. Spinal pumps allow for the customization of pain management plans. Healthcare providers can adjust the medication dosage and delivery rate to meet each patient's unique pain needs. This level of customization can lead to improved patient outcomes.

End-User Insights

In 2022, the Global Spinal Pumps Market largest share was held by Hospitals segment in the forecast period and is predicted to continue expanding over the coming years. Hospitals are equipped with specialized facilities, surgical suites, and trained medical personnel to perform complex medical procedures, including the implantation and management of spinal pumps. The placement and ongoing care of spinal pumps often require a hospital setting due to the need for surgical expertise and sterile environments. Hospitals typically have multidisciplinary care teams that include anesthesiologists, pain management specialists, neurosurgeons, and nurses who collaborate to provide comprehensive care for patients requiring spinal pump therapy. This coordinated approach ensures that patients receive optimal treatment and monitoring. Implanting and maintaining spinal pumps require surgical expertise. Hospitals have the necessary surgical facilities and teams to perform the surgical implantation of spinal pumps safely and effectively. This procedure may involve neurosurgical techniques. Hospitals are well-equipped to provide post-operative care and monitoring, ensuring that patients recover from the implantation procedure and experience a smooth transition to spinal pump therapy. This includes managing pain, addressing potential complications, and adjusting medication dosages.

Regional Insights

The North America region dominates the Global Spinal Pumps Market in 2022. Due to government legislation, the availability of a strong healthcare infrastructure, the high prevalence of birth abnormalities in the region, and new technological advancements in Nuclear Medicine Therapeutics technologies by the players operating in the region. The United States is predicted to have the greatest market share in the North American area. This is due to both the expanding need for sophisticated systems and the rising incidence rates of diseases in neonates. The study of diagnostic markers in blood spots collected on filter paper on an infant's second day of life is how every newborn in the United States is examined post-birth.

Key Market Players

DePuy Synthes Inc.

FlowonixMedical, Inc.

Medtronic Plc

Teleflex, Inc.

Tricumed Medizintechnik GmbH

Smith's Group Plc

Johnson & Johnson Private Limited

Becton & Dickinson Co.

Report Scope:

In this report, the Global Spinal Pumps Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Spinal Pumps Market, By Application:

• Malignant Pain
• Non-Malignant Pain
• Pain Management
• Spasticity Management

Spinal Pumps Market, By End-User:

• Alternate Care Centers
• ASCs
• Clinics
• Hospitals
• Long Term Care Centers

Global Spinal Pumps Market, By region:

• North America
• United States
• Canada
• Mexico
• Asia-Pacific
• China
• India
• South Korea
• Australia
• Japan
• Europe
• Germany
• France
• United Kingdom
• Spain
• Italy
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE

Competitive Landscape

• Company Profiles: Detailed analysis of the major companies present in the Global Spinal Pumps Market.

Available Customizations:

• Global Spinal Pumps Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Spinal Pumps Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Application (Malignant Pain, Non-Malignant Pain, Pain Management, Spasticity Management)
  • 5.2.2. By End-User (Alternate Care Centers, ASCs, Clinics, Hospitals, Long Term Care Centers)
  • 5.2.3. By Company (2022)
• 5.3. Market Map

6. Asia Pacific Spinal Pumps Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Application
  • 6.2.2. By End-User
  • 6.2.3. By Country
• 6.3. Asia Pacific: Country Analysis
  • 6.3.1. China Spinal Pumps Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Application
      • 6.3.1.2.2. By End-User
  • 6.3.2. India Spinal Pumps Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Application
      • 6.3.2.2.2. By End-User
  • 6.3.3. Australia Spinal Pumps Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Application
      • 6.3.3.2.2. By End-User
  • 6.3.4. Japan Spinal Pumps Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Application
      • 6.3.4.2.2. By End-User
  • 6.3.5. South Korea Spinal Pumps Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Application
      • 6.3.5.2.2. By End-User

7. Europe Spinal Pumps Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Application
  • 7.2.2. By End-User
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Spinal Pumps Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Application
      • 7.3.1.2.2. By End-User
  • 7.3.2. Germany Spinal Pumps Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Application
      • 7.3.2.2.2. By End-User
  • 7.3.3. Spain Spinal Pumps Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Application
      • 7.3.3.2.2. By End-User
  • 7.3.4. Italy Spinal Pumps Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Application
      • 7.3.4.2.2. By End-User
  • 7.3.5. United Kingdom Spinal Pumps Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Indication
      • 7.3.5.2.2. By Distribution Channel

8. North America Spinal Pumps Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Application
  • 8.2.2. By End-User
  • 8.2.3. By Country
• 8.3. North America: Country Analysis
  • 8.3.1. United States Spinal Pumps Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Application
      • 8.3.1.2.2. By End-User
  • 8.3.2. Mexico Spinal Pumps Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Application
      • 8.3.2.2.2. By End-User
  • 8.3.3. Canada Spinal Pumps Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Application
      • 8.3.3.2.2. By End-User

9. South America Spinal Pumps Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Application
  • 9.2.2. By End-User
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Spinal Pumps Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Application
      • 9.3.1.2.2. By End-User
  • 9.3.2. Argentina Spinal Pumps Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Application
      • 9.3.2.2.2. By End-User
  • 9.3.3. Colombia Spinal Pumps Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Application
      • 9.3.3.2.2. By End-User

10. Middle East and Africa Spinal Pumps Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Application
  • 10.2.2. By End-User
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Spinal Pumps Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Application
      • 10.3.1.2.2. By End-User
  • 10.3.2. Saudi Arabia Spinal Pumps Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Application
      • 10.3.2.2.2. By End-User
  • 10.3.3. UAE Spinal Pumps Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Application
      • 10.3.3.2.2. By End-User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Spinal Pumps Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Product

15. PESTLE Analysis

16. Competitive Landscape

• 16.1. Medtronic Plc.
  • 16.1.1. Business Overview
  • 16.1.2. Company Snapshot
  • 16.1.3. Products & Services
  • 16.1.4. Financials (In case of listed companies)
  • 16.1.5. Recent Developments
  • 16.1.6. SWOT Analysis
• 16.2. FlowonixMedical, Inc.
  • 16.2.1. Business Overview
  • 16.2.2. Company Snapshot
  • 16.2.3. Products & Services
  • 16.2.4. Financials (In case of listed companies)
  • 16.2.5. Recent Developments
  • 16.2.6. SWOT Analysis
• 16.3. Tricumed Medizintechnik GmbH
  • 16.3.1. Business Overview
  • 16.3.2. Company Snapshot
  • 16.3.3. Products & Services
  • 16.3.4. Financials (In case of listed companies)
  • 16.3.5. Recent Developments
  • 16.3.6. SWOT Analysis
• 16.4. Smith Group Plc
  • 16.4.1. Business Overview
  • 16.4.2. Company Snapshot
  • 16.4.3. Products & Services
  • 16.4.4. Financials (In case of listed companies)
  • 16.4.5. Recent Developments
  • 16.4.6. SWOT Analysis
• 16.5. Johnson & Johnson Private Limited
  • 16.5.1. Business Overview
  • 16.5.2. Company Snapshot
  • 16.5.3. Products & Services
  • 16.5.4. Financials (In case of listed companies)
  • 16.5.5. Recent Developments
  • 16.5.6. SWOT Analysis
• 16.6. Teleflex, Inc.
  • 16.6.1. Business Overview
  • 16.6.2. Company Snapshot
  • 16.6.3. Products & Services
  • 16.6.4. Financials (In case of listed companies)
  • 16.6.5. Recent Developments
  • 16.6.6. SWOT Analysis
• 16.7. Becton Dickinson & Co.
  • 16.7.1. Business Overview
  • 16.7.2. Company Snapshot
  • 16.7.3. Products & Services
  • 16.7.4. Financials (In case of listed companies)
  • 16.7.5. Recent Developments
  • 16.7.6. SWOT Analysis
• 16.8. DePuy Synthes Inc.
  • 16.8.1. Business Overview
  • 16.8.2. Company Snapshot
  • 16.8.3. Products & Services
  • 16.8.4. Financials (In case of listed companies)
  • 16.8.5. Recent Developments
  • 16.8.6. SWOT Analysis
  • 16.8.7. SWOT Analysis

17. Strategic Recommendations

About Us & Disclaimer